Pharmaceutical products; requiring manufacturers to publish certain list of ingredients; providing administrative, civil, and criminal penalties and remedies. Effective date.

SB 941 requires Oklahoma pharmaceutical manufacturers to publicly disclose detailed ingredient lists for all products, including prescription drugs, over-the-counter medications, vaccines, and research items. Manufacturers must list chemical names, origins (human/animal/synthetic), ingredient purposes, quantities, and specific details for mRNA/vaccine technologies like nucleic acid sequences and delivery mechanisms. This information must be submitted to the State Board of Pharmacy, published on manufacturer websites, and included in product labeling. Noncompliance incurs fines up to $250,000 per product per violation, potential sales bans, and allows affected individuals to sue for damages or file class actions. The law takes effect January 1, 2026.